glu-p-2 has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masuda, M; Mogami, M; Ohgaki, H; Sato, S; Sugimura, T; Takayama, S | 1 |
| Fukushima, S; Hakoi, K; Hasegawa, R; Ito, N; Iwasaki, S; Nagao, M; Shirai, T; Sugimura, T; Takaba, K; Wakabayashi, K | 1 |
2 other study(ies) available for glu-p-2 and Cancer of Liver
| Article | Year |
|---|---|
Induction of cancers in the intestine, liver and various other organs of rats by feeding mutagens from glutamic acid pyrolysate.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenoma; Animals; Female; Glutamates; Glutamic Acid; Imidazoles; Intestinal Neoplasms; Liver Neoplasms; Male; Mutagens; Rats; Rats, Inbred F344; Time Factors | 1984 |
Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
Topics: Animals; Body Weight; Carbolines; Carcinogens; Drug Synergism; Enzyme Induction; Glutathione Transferase; Imidazoles; Immunohistochemistry; Liver; Liver Neoplasms; Male; Organ Size; Quinolines; Quinoxalines; Rats; Rats, Inbred F344 | 1991 |